Chemotherapy Treatment Guides

FOLFOX is one of the most common chemotherapy regimens for colorectal cancer. It combines three drugs given over 2 days every 2 weeks.

FOLFIRI is a colorectal cancer chemotherapy regimen that replaces oxaliplatin with irinotecan. Often used after FOLFOX or when neuropathy is a concern.

FOLFIRINOX is an aggressive four-drug regimen used for pancreatic cancer and some colorectal cancers. It is highly effective but has significant side effects.

ABVD is the standard treatment for Hodgkin lymphoma. Four drugs are given on days 1 and 15 of each 28-day cycle.

R-CHOP is the standard treatment for B-cell non-Hodgkin lymphomas. Six drugs (including a targeted therapy) are given every 3 weeks.

AC-T (dose-dense) is a common breast cancer regimen. Four cycles of AC are given every 2 weeks, followed by four cycles of Taxol every 2 weeks.

Carboplatin + Paclitaxel is a widely used regimen across several cancer types. Given every 3 weeks for 6 cycles.

Gemcitabine + Cisplatin is used for bladder, lung, and other cancers. Given over 3 weeks with a rest week.

Escalated BEACOPP is used for advanced Hodgkin lymphoma when ABVD is insufficient. It is more intensive with a higher side effect burden.

CMF is an older breast cancer regimen still used in some settings. Less intense than AC-T but still effective for certain patients.